Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh Do

Showing results (231-240 of 379) with videos related to

Pageof 38
Sort By:
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Biomarkers of response to Akt inhibitor MK-2206 in breast cancerTakafumi Sangai, Argun Akcakanat, Huiqin Chen, et al.
Innovations (Philadelphia, Pa.)|November 2, 2024
Results of Vertical Infra-Axillary Thoracotomy for Total Repair of Tetralogy of FallotTien Anh Do, Bao Tuan Luong, Tran Thuy Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Relationship between epidemiologic risk factors and breast cancer recurrenceAbenaa M Brewster, Kim-Anh Do, Patricia A Thompson, et al.
Leukemia Research|May 4, 2004
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphomaFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Respirology Case Reports|April 10, 2023
Severe COVID-19 pneumonia in pregnant woman treated with pulse corticosteroids therapy and third-trimester caesarean section: A case reportNghia Thinh Bui, Minh Nhat Huynh, Hung Tran, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Cancer|August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodiesMaher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
Journal of the National Cancer Institute|June 8, 2006
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancerSun-Jin Kim, Hisanori Uehara, Sertac Yazici, et al.
Cancer Letters|May 8, 2025
ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacyShuying Liu, Huiqin Chen, Mihai Gagea, et al.
Pageof 38

Showing results (231-240 of 379) with videos related to

Sort By:
Pageof 38
The Prostate|September 21, 2007
Employing the treatment-free interval of intermittent androgen ablation to screen candidate prostate cancer therapiesShifeng Mao, Danai D Daliani, Xuemei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2012
Biomarkers of response to Akt inhibitor MK-2206 in breast cancerTakafumi Sangai, Argun Akcakanat, Huiqin Chen, et al.
Innovations (Philadelphia, Pa.)|November 2, 2024
Results of Vertical Infra-Axillary Thoracotomy for Total Repair of Tetralogy of FallotTien Anh Do, Bao Tuan Luong, Tran Thuy Nguyen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Relationship between epidemiologic risk factors and breast cancer recurrenceAbenaa M Brewster, Kim-Anh Do, Patricia A Thompson, et al.
Leukemia Research|May 4, 2004
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphomaFrancis J Giles, Julie M Vose, Kim-Anh Do, et al.
Respirology Case Reports|April 10, 2023
Severe COVID-19 pneumonia in pregnant woman treated with pulse corticosteroids therapy and third-trimester caesarean section: A case reportNghia Thinh Bui, Minh Nhat Huynh, Hung Tran, et al.
Nature Biotechnology|December 24, 2002
Fingerprinting the circulating repertoire of antibodies from cancer patientsPaul J Mintz, Jeri Kim, Kim-Anh Do, et al.
Cancer|August 27, 2004
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodiesMaher Albitar, Kim-Anh Do, Marcella M Johnson, et al.
Journal of the National Cancer Institute|June 8, 2006
Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancerSun-Jin Kim, Hisanori Uehara, Sertac Yazici, et al.
Cancer Letters|May 8, 2025
ADAMs contribute to triple negative breast cancer via mTORC1 pathway: targeting ADAM-mTOR axis improves efficacyShuying Liu, Huiqin Chen, Mihai Gagea, et al.
Pageof 38